Our top pick for
Inpixon is a software-application business based in the US. Inpixon shares (INPX) are listed on the NASDAQ and all prices are listed in US Dollars. Inpixon employs 184 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$0.83|
|52-week range||$0.73 - $2.89|
|50-day moving average||$0.90|
|200-day moving average||$1.04|
|Wall St. target price||$0.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.20|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||4.06%|
|1 month (2021-09-23)||-6.16%|
|3 months (2021-07-23)||-18.62%|
|6 months (2021-04-23)||-28.44%|
|1 year (2020-10-22)||-21.69%|
|2 years (2019-10-22)||698.94%|
|3 years (2018-10-22)||245.59%|
|5 years (2016-10-21)||295.47%|
|Revenue TTM||$12.8 million|
|Gross profit TTM||$6.7 million|
|Return on assets TTM||-19.97%|
|Return on equity TTM||-14.56%|
|Market capitalisation||$93.3 million|
TTM: trailing 12 months
There are currently 3.2 million Inpixon shares held short by investors – that's known as Inpixon's "short interest". This figure is 32.5% down from 4.8 million last month.
There are a few different ways that this level of interest in shorting Inpixon shares can be evaluated.
Inpixon's "short interest ratio" (SIR) is the quantity of Inpixon shares currently shorted divided by the average quantity of Inpixon shares traded daily (recently around 2.1 million). Inpixon's SIR currently stands at 1.57. In other words for every 100,000 Inpixon shares traded daily on the market, roughly 1570 shares are currently held short.
However Inpixon's short interest can also be evaluated against the total number of Inpixon shares, or, against the total number of tradable Inpixon shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Inpixon's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Inpixon shares in existence, roughly 30 shares are currently held short) or 0.0282% of the tradable shares (for every 100,000 tradable Inpixon shares, roughly 28 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Inpixon.
Find out more about how you can short Inpixon stock.
We're not expecting Inpixon to pay a dividend over the next 12 months.
Inpixon's shares were split on a 1:45 basis on 6 January 2020. So if you had owned 45 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Inpixon shares – just the quantity. However, indirectly, the new 4400% higher share price could have impacted the market appetite for Inpixon shares which in turn could have impacted Inpixon's share price.
Over the last 12 months, Inpixon's shares have ranged in value from as little as $0.725 up to $2.89. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Inpixon's is 2.1868. This would suggest that Inpixon's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Inpixon, together with its subsidiaries, provides big data analytics and location based products and related services worldwide. It offers Inpixon Sensor 4000, a passive RF sensor to detect signals ranging from pings to a cell tower to active wireless transmissions; Inpixon IPA Pod offers entry-level barriers to radio detection based indoor positioning; Inpixon Smart School Safety Network solution, a combination of wristbands, ID badges, gateways, and proprietary backend software for school; UWB Sensor Module helps in detection with location; Inpixon GPS 900, a personnel, vehicle, and asset tracking solution; IPA Security, a mobile security and detection product that locates devices operating within a monitored area; Inpixon MDM Connector enables two-way communication between our IPA Security platform and a third-party mobile device management system; Inpixon On-Premises Analytics security customers running systems; and Inpixon GPS Viewer, a browser-based portal used to monitor location and movements of GPS-enabled tracking devices. The company also offers data analytics solutions, such as IPA Wi-Fi, a cloud-based data analytics engine that provides visitor metrics and insights by ingesting diverse data from IoT, third-party, and proprietary sensors; IPA Video analytics to help security personnel combat crime and secure indoor locations; Inpixon Captive Portal, a splash page for their customers to accept terms and conditions before using Wi-Fi; and Shoom Products cloud based applications and analytics for the media and publishing industry. It serves shopping malls, corporate offices, healthcare facilities, government agencies, local publications, and others. The company was formerly known as Sysorex Global and changed its name to Inpixon in March 2017. Inpixon is headquartered in Palo Alto, California. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.